Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 3, no: 8 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HPS5
Term | Name | Level | Count |
---|---|---|---|
GO:0006470 | protein dephosphorylation | 5 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0010638 | positive regulation of organelle organization | 6 | 1 |
GO:0010821 | regulation of mitochondrion organization | 6 | 1 |
GO:0010822 | positive regulation of mitochondrion organization | 7 | 1 |
GO:0016311 | dephosphorylation | 5 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0022603 | regulation of anatomical structure morphogenesis | 4 | 1 |
GO:0033043 | regulation of organelle organization | 5 | 1 |
GO:0035970 | peptidyl-threonine dephosphorylation | 6 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0048518 | positive regulation of biological process | 3 | 1 |
GO:0048522 | positive regulation of cellular process | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050793 | regulation of developmental process | 3 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0051094 | positive regulation of developmental process | 4 | 1 |
GO:0051128 | regulation of cellular component organization | 4 | 1 |
GO:0051130 | positive regulation of cellular component organization | 5 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090140 | regulation of mitochondrial fission | 5 | 1 |
GO:0090141 | positive regulation of mitochondrial fission | 5 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 1 |
GO:0004722 | protein serine/threonine phosphatase activity | 4 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0016791 | phosphatase activity | 5 | 1 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 138 | 140 | PF00675 | 0.395 |
CLV_NRD_NRD_1 | 147 | 149 | PF00675 | 0.381 |
CLV_NRD_NRD_1 | 228 | 230 | PF00675 | 0.448 |
CLV_NRD_NRD_1 | 6 | 8 | PF00675 | 0.533 |
CLV_PCSK_KEX2_1 | 147 | 149 | PF00082 | 0.361 |
CLV_PCSK_KEX2_1 | 228 | 230 | PF00082 | 0.305 |
CLV_PCSK_KEX2_1 | 6 | 8 | PF00082 | 0.566 |
CLV_PCSK_PC1ET2_1 | 147 | 149 | PF00082 | 0.458 |
CLV_PCSK_SKI1_1 | 139 | 143 | PF00082 | 0.505 |
CLV_PCSK_SKI1_1 | 160 | 164 | PF00082 | 0.429 |
CLV_PCSK_SKI1_1 | 180 | 184 | PF00082 | 0.331 |
CLV_PCSK_SKI1_1 | 186 | 190 | PF00082 | 0.568 |
CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.407 |
CLV_PCSK_SKI1_1 | 249 | 253 | PF00082 | 0.502 |
CLV_PCSK_SKI1_1 | 290 | 294 | PF00082 | 0.322 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.511 |
DEG_APCC_DBOX_1 | 147 | 155 | PF00400 | 0.416 |
DOC_CYCLIN_RxL_1 | 136 | 146 | PF00134 | 0.468 |
DOC_CYCLIN_RxL_1 | 290 | 302 | PF00134 | 0.235 |
DOC_MAPK_gen_1 | 129 | 138 | PF00069 | 0.452 |
DOC_MAPK_gen_1 | 211 | 220 | PF00069 | 0.390 |
DOC_MAPK_gen_1 | 6 | 14 | PF00069 | 0.546 |
DOC_MAPK_MEF2A_6 | 7 | 16 | PF00069 | 0.526 |
DOC_PP2B_LxvP_1 | 297 | 300 | PF13499 | 0.235 |
DOC_PP4_FxxP_1 | 269 | 272 | PF00568 | 0.250 |
DOC_USP7_MATH_1 | 247 | 251 | PF00917 | 0.471 |
DOC_USP7_MATH_1 | 272 | 276 | PF00917 | 0.381 |
DOC_USP7_MATH_1 | 310 | 314 | PF00917 | 0.261 |
DOC_USP7_MATH_1 | 92 | 96 | PF00917 | 0.551 |
DOC_WW_Pin1_4 | 16 | 21 | PF00397 | 0.590 |
DOC_WW_Pin1_4 | 31 | 36 | PF00397 | 0.534 |
LIG_14-3-3_CanoR_1 | 211 | 220 | PF00244 | 0.296 |
LIG_14-3-3_CanoR_1 | 249 | 258 | PF00244 | 0.391 |
LIG_14-3-3_CanoR_1 | 290 | 295 | PF00244 | 0.295 |
LIG_14-3-3_CanoR_1 | 306 | 310 | PF00244 | 0.264 |
LIG_14-3-3_CanoR_1 | 94 | 103 | PF00244 | 0.397 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.575 |
LIG_BRCT_BRCA1_1 | 1 | 5 | PF00533 | 0.559 |
LIG_CtBP_PxDLS_1 | 337 | 341 | PF00389 | 0.400 |
LIG_FHA_1 | 213 | 219 | PF00498 | 0.321 |
LIG_FHA_1 | 24 | 30 | PF00498 | 0.653 |
LIG_FHA_1 | 276 | 282 | PF00498 | 0.326 |
LIG_FHA_1 | 320 | 326 | PF00498 | 0.262 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.414 |
LIG_FHA_2 | 275 | 281 | PF00498 | 0.281 |
LIG_FHA_2 | 62 | 68 | PF00498 | 0.460 |
LIG_LIR_Apic_2 | 266 | 272 | PF02991 | 0.269 |
LIG_LIR_Apic_2 | 73 | 77 | PF02991 | 0.417 |
LIG_LIR_Apic_2 | 80 | 85 | PF02991 | 0.339 |
LIG_LIR_Nem_3 | 2 | 8 | PF02991 | 0.572 |
LIG_LIR_Nem_3 | 262 | 268 | PF02991 | 0.255 |
LIG_LIR_Nem_3 | 332 | 336 | PF02991 | 0.388 |
LIG_PCNA_yPIPBox_3 | 44 | 57 | PF02747 | 0.351 |
LIG_Pex14_2 | 265 | 269 | PF04695 | 0.250 |
LIG_Pex14_2 | 5 | 9 | PF04695 | 0.529 |
LIG_PTB_Apo_2 | 51 | 58 | PF02174 | 0.485 |
LIG_Rb_pABgroove_1 | 51 | 59 | PF01858 | 0.418 |
LIG_SH2_STAT5 | 137 | 140 | PF00017 | 0.394 |
LIG_SH2_STAT5 | 268 | 271 | PF00017 | 0.235 |
LIG_SH2_STAT5 | 291 | 294 | PF00017 | 0.282 |
LIG_SH2_STAT5 | 70 | 73 | PF00017 | 0.440 |
LIG_SH3_3 | 32 | 38 | PF00018 | 0.657 |
LIG_SUMO_SIM_anti_2 | 277 | 283 | PF11976 | 0.257 |
LIG_SUMO_SIM_par_1 | 339 | 344 | PF11976 | 0.483 |
LIG_TRAF2_1 | 170 | 173 | PF00917 | 0.439 |
LIG_TRAF2_1 | 63 | 66 | PF00917 | 0.405 |
MOD_CDK_SPxxK_3 | 16 | 23 | PF00069 | 0.525 |
MOD_CK1_1 | 207 | 213 | PF00069 | 0.323 |
MOD_CK1_1 | 275 | 281 | PF00069 | 0.278 |
MOD_CK2_1 | 274 | 280 | PF00069 | 0.240 |
MOD_CK2_1 | 61 | 67 | PF00069 | 0.469 |
MOD_GlcNHglycan | 189 | 192 | PF01048 | 0.396 |
MOD_GlcNHglycan | 253 | 256 | PF01048 | 0.469 |
MOD_GlcNHglycan | 274 | 277 | PF01048 | 0.300 |
MOD_GlcNHglycan | 47 | 50 | PF01048 | 0.579 |
MOD_GlcNHglycan | 93 | 97 | PF01048 | 0.487 |
MOD_GSK3_1 | 247 | 254 | PF00069 | 0.425 |
MOD_GSK3_1 | 270 | 277 | PF00069 | 0.201 |
MOD_GSK3_1 | 315 | 322 | PF00069 | 0.347 |
MOD_N-GLC_1 | 111 | 116 | PF02516 | 0.325 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.561 |
MOD_NEK2_1 | 29 | 34 | PF00069 | 0.617 |
MOD_NEK2_1 | 305 | 310 | PF00069 | 0.235 |
MOD_NEK2_1 | 8 | 13 | PF00069 | 0.495 |
MOD_NEK2_2 | 111 | 116 | PF00069 | 0.526 |
MOD_PKA_1 | 180 | 186 | PF00069 | 0.275 |
MOD_PKA_2 | 121 | 127 | PF00069 | 0.383 |
MOD_PKA_2 | 131 | 137 | PF00069 | 0.330 |
MOD_PKA_2 | 270 | 276 | PF00069 | 0.184 |
MOD_PKA_2 | 305 | 311 | PF00069 | 0.249 |
MOD_PKA_2 | 319 | 325 | PF00069 | 0.249 |
MOD_Plk_1 | 111 | 117 | PF00069 | 0.529 |
MOD_Plk_2-3 | 168 | 174 | PF00069 | 0.444 |
MOD_Plk_4 | 323 | 329 | PF00069 | 0.410 |
MOD_Plk_4 | 8 | 14 | PF00069 | 0.577 |
MOD_ProDKin_1 | 16 | 22 | PF00069 | 0.590 |
MOD_ProDKin_1 | 31 | 37 | PF00069 | 0.530 |
MOD_SUMO_rev_2 | 113 | 120 | PF00179 | 0.391 |
MOD_SUMO_rev_2 | 173 | 183 | PF00179 | 0.543 |
TRG_DiLeu_BaLyEn_6 | 17 | 22 | PF01217 | 0.520 |
TRG_ENDOCYTIC_2 | 291 | 294 | PF00928 | 0.329 |
TRG_ENDOCYTIC_2 | 333 | 336 | PF00928 | 0.390 |
TRG_ER_diArg_1 | 227 | 229 | PF00400 | 0.396 |
TRG_ER_diArg_1 | 5 | 7 | PF00400 | 0.565 |
TRG_NLS_Bipartite_1 | 147 | 167 | PF00514 | 0.432 |
TRG_NLS_MonoExtC_3 | 162 | 168 | PF00514 | 0.420 |
TRG_NLS_MonoExtN_4 | 147 | 152 | PF00514 | 0.419 |
TRG_NLS_MonoExtN_4 | 160 | 167 | PF00514 | 0.307 |
TRG_Pf-PMV_PEXEL_1 | 139 | 143 | PF00026 | 0.428 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P665 | Leptomonas seymouri | 65% | 100% |
A0A0N0P6K6 | Leptomonas seymouri | 61% | 100% |
A0A0S4J0R9 | Bodo saltans | 34% | 98% |
A0A1X0P349 | Trypanosomatidae | 50% | 100% |
A0A3S7XBE7 | Leishmania donovani | 86% | 100% |
A4ICY8 | Leishmania infantum | 85% | 100% |
B3MR30 | Drosophila ananassae | 32% | 100% |
B3P9N0 | Drosophila erecta | 32% | 100% |
B4GXS1 | Drosophila persimilis | 32% | 100% |
B4I9J6 | Drosophila sechellia | 31% | 100% |
B4JMM7 | Drosophila grimshawi | 34% | 100% |
B4L6S9 | Drosophila mojavensis | 31% | 100% |
B4M7S0 | Drosophila virilis | 33% | 100% |
B4NE96 | Drosophila willistoni | 33% | 100% |
B4PY69 | Drosophila yakuba | 32% | 100% |
B4R313 | Drosophila simulans | 31% | 100% |
D0A8P0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9ATJ0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
O46084 | Drosophila melanogaster | 31% | 100% |
Q29HG0 | Drosophila pseudoobscura pseudoobscura | 33% | 100% |
Q4Q108 | Leishmania major | 84% | 100% |
Q562B5 | Rattus norvegicus | 32% | 100% |
Q8BX10 | Mus musculus | 31% | 100% |
Q96HS1 | Homo sapiens | 31% | 100% |
V5B6V2 | Trypanosoma cruzi | 53% | 100% |